|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2006-9-14
|
|
pubmed:abstractText |
The relationship between postmenopausal hormone therapy (HT) and cerebrovascular disease has been examined in several epidemiological studies and clinical trials with conflicting results. The authors aimed to evaluate the association between the use of HT and the incidence of first cerebrovascular event.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1072-3714
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
13
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
730-6
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16946686-Aged,
pubmed-meshheading:16946686-Brain Ischemia,
pubmed-meshheading:16946686-Case-Control Studies,
pubmed-meshheading:16946686-Cerebral Hemorrhage,
pubmed-meshheading:16946686-Cohort Studies,
pubmed-meshheading:16946686-Confidence Intervals,
pubmed-meshheading:16946686-Estrogen Replacement Therapy,
pubmed-meshheading:16946686-Female,
pubmed-meshheading:16946686-Great Britain,
pubmed-meshheading:16946686-Humans,
pubmed-meshheading:16946686-Incidence,
pubmed-meshheading:16946686-Ischemic Attack, Transient,
pubmed-meshheading:16946686-Middle Aged,
pubmed-meshheading:16946686-Odds Ratio,
pubmed-meshheading:16946686-Postmenopause,
pubmed-meshheading:16946686-Risk Factors,
pubmed-meshheading:16946686-Stroke
|
|
pubmed:articleTitle |
Hormone therapy and cerebrovascular events: a population-based nested case-control study.
|
|
pubmed:affiliation |
Novartis, Clinical Safety and Epidemiology, Madrid, Spain.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
